# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hemoglobin C disease

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-8 of 8 results.
Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
Status: Unknown status
Last Changed: Aug 08, 2018
First Received: Aug 08, 2018
Disease(s): Diagnoses Disease
Intervention(s): HemoTypeSC
Locations: Silver Lake Research Corporation, Azusa, California, United States
Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients
Status: Completed
Last Changed: Apr 11, 2016
First Received: Oct 08, 2015
Disease(s): Sickle Cell Hemoglobin C Disease, Hemoglobin S Disease
Intervention(s): Training Program
Locations: Hopital Avicenne, Bobigny, France
Centre hospitalier sud francilien, Corbeil-essonnes, France
CHU Henri MONDOR, Creteil, France
CHU Kremlin-Bicêtre, Le Kremlin Bicetre, France
Hopital Europeen Georges POMPIDOU, Paris, France
... and 5 other locations.
Treatment of Sickle Cell Anemia With Stem Cell Transplant
Status: Terminated
Last Changed: Nov 29, 2016
First Received: May 09, 2011
Disease(s): Sickle Cell Anemia, Sickle Cell-hemoglobin C Disease, Sickle Cell-β0-thalassemia
Intervention(s): Fludarabine, Cytarabine, Cellular Infusions, Total Body Irradiation, Cyclophosphamide, Bortezomib, Rituximab, Plasmapheresis
Locations: Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Status: Withdrawn
Last Changed: Oct 28, 2013
First Received: Aug 19, 2013
Disease(s): Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders, Hemoglobin SC Disease, Sickle Cell Hemoglobin C Disease
Intervention(s): MP4CO, Sodium chloride solution
Locations: Salmaniya Medical Complex, Manama, Bahrain
University Hospital Brugmann, Brussels, Belgium
Rio de Janerio Instituto Estadual de Hematologie, Rio de Janerio, Brazil
Hôpital Henri Mondor, Créteil, France
Georges Pompidou European University Hospital, Paris, France
... and 10 other locations.
Safety Study of MP4CO in Adult Sickle Cell Patients
Status: Completed
Last Changed: Aug 19, 2013
First Received: May 19, 2011
Disease(s): Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders, Hemoglobin SC Disease, Sickle Cell Hemoglobin C Disease
Intervention(s): MP4CO, Sodium chloride solution
Locations: Hôpital Henri Mondor, Creteil, France
Sickle Cell Unit, University of West Indies, Kingston, Jamaica
Rafic Hariri University Hospital, Beirut, Lebanon
Guy's Hospital, London, United Kingdom
King's College London, London, United Kingdom
... and 1 other locations.
Far Infrared Radiation for Sickle Cell Pain Management
Status: Unknown status
Last Changed: Jan 05, 2009
First Received: Jan 23, 2008
Disease(s): Anemia, Sickle Cell
Intervention(s): Far Infrared Radiation (5μm to 20μm wavelength)
Locations: The Centre for Incurable Diseases, Mississauga, Ontario, Canada
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Status: Completed
Last Changed: Jul 30, 2013
First Received: Sep 12, 2005
Disease(s): Hemoglobinopathies, Sickle Cell Disease, Thalassemia
Intervention(s): Busulfex, Fludarabine, Alemtuzumab, Stem Cell Transfusion
Locations: Winship Cancer Institute-Emory University, Atlanta, Georgia, United States
Feist-Weiller Cancer Center-LSU, Shreveport, Louisiana, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
... and 2 other locations.
Pharmacokinetics of Oral Hydroxyurea Solution
Status: Recruiting
Last Changed: Sep 12, 2019
First Received: Dec 04, 2018
Disease(s): Sickle Cell Disease, Sickle-Cell; Hemoglobin Disease, Thalassemia, Sickle Cell-beta-thalassemia, Sickle Cell Hemoglobin C
Intervention(s): Hydroxy Urea
Locations: Dr Angela E Rankine- Mullings, Kingston, Jamaica
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom
Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom
Evelina London Children's Hospital, London, United Kingdom
King's College Hospital NHS Foundation Trust, London, United Kingdom
... and 2 other locations.